{"public_id":"co_735f8b3565d22d3ba0080e29dd6e662d","status":"active","merged_into_public_id":null,"resolved_public_id":"co_735f8b3565d22d3ba0080e29dd6e662d","name":"existing vaccine strains","description":"The virus strains used in the currently available feline calicivirus vaccines.","aliases":[],"types":["viral strains"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":25350561,"title":"Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.","citation_count":25,"url":"https://sah.borca.ai/papers/25350561"}],"claims":[{"public_id":"cl_27a4490ed666ae6d6469be291df227d9","text":"Neutralizing antigenicity differs greatly between the existing vaccine strains and feline calicivirus strains prevalent in Japan.","corpus_id":25350561,"url":"https://sah.borca.ai/claims/cl_27a4490ed666ae6d6469be291df227d9"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_735f8b3565d22d3ba0080e29dd6e662d","url":"https://sah.borca.ai/concepts/co_735f8b3565d22d3ba0080e29dd6e662d"}